Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quest LaboratoriesNSE:QUESTLAB -0.61%46 Gross Margin % is 23.32% as of Mar. 2026, which is 2% below its 10-year median of 23.70. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 46/100. The stock has 5 warning signs investors should review. Among 940 Drug Manufacturers companies, Quest Laboratories ranks worse than 89.47% on this metric.
The historical rank and industry rank for Quest Laboratories's Gross Margin % or its related term are showing as below:
NSE:QUESTLAB'
s Gross Margin % Range Over the Past 10 Years
Min: 19.17 Med: 23.7 Max: 34.92
Current: 21.77
During the past 6 years, the highestGross Margin % of Quest Laboratories was 34.92%. The lowest was 19.17%. And the median was 23.70%.
NSE:QUESTLAB's Gross Margin % is ranked worse than 89.47% of 940
companies
in the Drug Manufacturers industry
Industry Median: 48.35
vs NSE:QUESTLAB: 21.77
Quest Laboratories had a gross margin of 23.32% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Quest Laboratories was 1.40% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Quest Laboratories had a gross margin of 23.32% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Quest Laboratories Gross Margin % Related Terms
Quest Laboratories Gross Margin % Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Quest Laboratories (NSE:QUESTLAB) has a Gross Margin % of 23.32% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Quest Laboratories and its competitors. This is near median its historical median of 23.70. Over the past decade, Quest Laboratories' Gross Margin % has ranged from 19.17 to 34.92. According to the industry distribution chart, Quest Laboratories ranks #841 out of 940 companies in the Drug Manufacturers industry, placing it in the top 89.5%.
Is Quest Laboratories' Gross Margin % too high?
Quest Laboratories' current Gross Margin % of 23.32% is near median its 10-year median of 23.70. Over the past 10 years, this metric has ranged from a low of 19.17 to a high of 34.92. The Drug Manufacturers industry median Gross Margin % is 48.35. Quest Laboratories' value of 23.32% is 51.8% below this industry median. Based on the distribution chart, Quest Laboratories ranks #841 out of 940 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Quest Laboratories has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #841 out of 940 companies for Gross Margin %. This places Quest Laboratories in the lower half of its industry. The industry median Gross Margin % is 48.35. Quest Laboratories' value of 23.32% is 51.8% below this benchmark. Historically, Quest Laboratories' own Gross Margin % has ranged from 19.17 to 34.92 over the past decade. While the company's 10-year median is 23.70 vs. the industry median of 48.35, Quest Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.35, based on 940 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current Gross Margin % of 23.32% is 51.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current Gross Margin % is 23.32%, which is near median its own 10-year median of 23.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Gross Margin % of 23.32%. The current Gross Margin % is 23.32%, which is near median its 10-year median of 23.70 and 51.8% below the Drug Manufacturers industry median of 48.35. Quest Laboratories' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Gross Margin % is 23.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
46GF Score
Get the complete analysis for NSE:QUESTLAB
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 
